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Abstract The recent identi¢cation of stem cell pools in a vari-
ety of unexpected tissue sources has raised the possibility that a
pluripotent stem cell population may reside in the myocardium
and contribute to the post-natal growth of this tissue. Here, we
demonstrate that the post-natal myocardium contains a resident
verapamil-sensitive side population (SP), with stem cell-like ac-
tivity. When growth of the post-natal heart was attenuated
through over-expression of a dominant negative cardiac tran-
scription factor (MEF2C), the resident SP cell population was
subject to activation, followed by a consequent depletion. In
addition, cardiac SP cells are capable of fusion with other cell
types, but do not adopt the corresponding gene expression pro-
¢le. These observations suggest that a responsive stem cell pool
resides in the adult myocardium, and may in£uence adaptation
of the post-natal heart.
- 2002 Published by Elsevier Science B.V. on behalf of the
Federation of European Biochemical Societies.
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1. Introduction
The adult heart retains a remarkable ability to adapt in-
trinsic cellular properties to alterations in the exterior milieu.
A most critical aspect of this phenomenon is the synchronous
pacing which matches myocardial enlargement to the growth
of the individual in either pre- or post-natal life. During fetal
development, myocardial growth is derived from proliferation
of the existing cardiomyocyte population. This phenomenon is
characterized by an elevated expression/activity of proteins
that accelerate the cardiomyocyte cell cycle, concurrent to a
repression of cell cycle inhibitors [1]. The gestational growth
of the myocardium is followed by an equally dramatic expan-
sion in heart size, which accompanies the transition from early
post-natal life to maturity. Irrespective of the phenotypic sim-
ilarity, the cellular adaptations that mediate fetal and post-
natal growth of the myocardium are clearly divergent. Specif-
ically, the proliferative capacity of cardiomyocytes is pro-
foundly diminished at later stages of pre-natal life [2^5]. At
this juncture, ambient growth of the myocardium is believed
to be primarily derived from hypertrophy of individual car-
diac myocytes [6^7]. This cellular adaptation is characterized
by a number of features common to cells of a muscle lineage
(cardiac and skeletal), including sarcomeric reorganization/
myo¢bril assembly and enhanced contractile activity [8].
Despite the documented hypertrophy of the cardiomyocyte
population, the potential for additional growth mechanisms in
the post-natal myocardium cannot be excluded. For example,
pluripotent bone marrow-derived stem cells have been shown
to retain the capacity to form cardiomyocytes when directly
injected into injured myocardial tissue [9,10]. These studies
raise a number of interesting questions, paramount of which
is the possibility that the post-natal heart may contain an
endogenous population of stem cells programmed to contrib-
ute to myocardial growth. Indeed, many terminally di¡eren-
tiated tissues including the nervous system and skeletal muscle
have been shown to harbor a population of cells with stem
cell-like activity, which also maintain site-speci¢c functions
[11^14]. In the present study we report the novel observation
that the adult myocardium retains an endogenous stem cell-
like population, which is activated during growth challenge.
2. Materials and methods
2.1. Animal models
The transgenic models utilized were previously characterized: the
Z/AP [15] and EGFP [16] mice as marker strains and the MEF2Cdn
as a myocardial hypoplastic model [17]. Unless otherwise indicated,
all subsequent experiments and primary cell derivations were per-
formed with age-matched animals V2 months.
2.2. Isolation of cardiac cell suspensions and cell culture
Primary cell cultures were prepared from ventricles and skeletal
muscle as described previously ([18,19], respectively). Puri¢cation of
primary cardiomyocytes was achieved with serial pre-plating in serum-
depleted media. For co-culturing experiments, approximately 10 000
cells from the Z/AP or EGFP cardiac cell suspensions were plated
with the indicated primary cultures (at 75% con£uence) or in 3 ml
of methocult medium (Stem Cell Technologies) for 14 days to assess
hematopoietic potential [20]. To induce di¡erentiation in primary de-
rived and established muscle cell lines, cultures were maintained in 2%
horse serum for the indicated time periods.
2.3. FACS sorting/pro¢ling
Cardiac cell suspensions were isolated as described previously [19]
and subject to Hoechst staining, verapamil treatment and £uores-
cence-activated cell sorter (FACS) analysis as previously described
[20]. FACS was performed using a Becton-Dickinson FacStar £ow
cytometer equipped with dual lasers. Fluorescence was measured at
two wavelengths using a 424BP44 ¢lter for blue emissions and a 650
LP ¢lter for red emissions. A 640 DMSP mirror was used to separate
wavelengths.
2.4. Immunohisto- and immunocytochemistry
Hearts were ¢xed in 4% paraformaldehyde, sectioned midsagitally
(6 Wm) and counterstained with 0.05% toluidine blue [21]. Primary
colonies isolated from methocult medium were ¢xed and stained as
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described in [25] using anti-mouse GR-1/Ly-6G (Pharmingen), and
anti-mouse integrin KM (M1-70)(Mac-1) (Pharmingen). Cardiac and
skeletal muscle cells were ¢xed in 4% paraformaldehyde and stained
for the following epitopes: connexin 43 (1:200, Chemicon); myogenin
(1:5, Developmental Studies Hybridoma Bank) both with Cy3-conju-
gated goat anti-mouse IgG secondary (Chemicon); L-galactosidase
(1:250, Abcam) with Cy3-conjugated goat anti-rabbit secondary
(Jackson). Enzymatic L-galactosidase staining was performed as de-
scribed in [21]. Immuno£uorescence was visualized using a Zeiss Ax-
ioscope microscope.
3. Results and discussion
Prior studies using a variety of tissue sources have deter-
mined that Hoechst dye-stained cell suspensions reveal a
Hoechst e¥uxing sub-population of cells (side population or
SP cells). These cells possess stem cell-like activity, reduction
or absence of di¡erentiation markers, and are also character-
ized by a sensitivity to the presence of verapamil, an inhibitor
of multi-drug resistance-like proteins [22^24]. Therefore, to
evaluate the presence of a resident myocardial stem cell pop-
ulation, hearts of mature C57Bl6 mice (V2 months) were
enzymatically dissociated into a single cell suspension and
subjected to FACS analyses. FACS analyses of the myocar-
dial cell suspensions revealed a robust Hoechst dye-excluding
SP population, which representedV1% of the total cell num-
ber in the adult heart (Fig. 1A). To test for lineage speci¢city,
we puri¢ed myocardial SP cells from the EGFP strain of
transgenic marker mice [16] and performed co-culture experi-
ments with primary cardiomyocytes derived from non-marker
mice of a similar genetic background (C57Bl6). These puri¢ed
myocardial SP cells from EGFP mice were capable of forming
cardiomyocytes under these co-culture conditions (as evi-
denced by co-localization of GFP and connexin 43 staining,
Fig. 1C^E). We also monitored the activity of the cardiac cell
suspensions (SPs and primary cardiomyocytes) using media
preparations that promote the expansion of stem cells and
stem cell progeny, i.e. methylcellulose stem cell medium [20].
Cells cultured in this manner gave rise to a number of pre-
sumptive stem cell colonies, at a low frequency ofV1 colony
per 50 000 cells plated. Of interest, a portion of these sus-
pended colonies became attached to surface adhered primary
cardiomyocytes. Subsequently, the size of these colonies de-
clined over time as the underlying cardiomyocyte colonies
expanded and began rhythmic contractions (Fig. 1F^H).
Subsequently, we investigated the physiological response of
this population to a myocardial growth challenge, i.e. do myo-
cardial SP cell populations change with altered physiologic
demands? Within this context, we compared the myocardial
SP population from wild-type mice and MEF2C dominant
negative (MEF2Cdn) mice. Previous studies from our labora-
tory have con¢rmed that cardiomyocyte-speci¢c over-expres-
sion of a dominant negative MEF2C protein (MEF2Cdn)
results in a substantial reduction in the size of individual
cardiomyocytes leading to a post-natal hypoplastic myocardi-
um (Fig. 2A,B; [17]). The MEF2Cdn strain is also unique in
that there are no additional pathologic features such as ¢bro-
sis or immune cell in¢ltration, which are common to most
models of cardiac insu⁄ciency or damage. Quanti¢cation
of the SP population from age-matched wild-type and
MEF2Cdn hearts revealed a substantial reduction in the per-
centage of verapamil-sensitive SP cells in the MEF2Cdn ge-
notype (V2.5-fold; Fig. 2C^G). The reduction was signi¢cant
and reproducible (P6 0.05). These experiments did not spec-
ify the fate of the reduced SP cell population in the MEF2Cdn
myocardium. Nevertheless, the concurrent increase in total
cardiomyocyte number in this model suggests that the deleted
SP cells were recruited and/or activated by the attenuation of
post-natal cardiac growth. Indeed, cardiomyocyte counts in
the MEF2Cdn are approximately 2.3-fold higher than in
age-matched control myocardium, which is remarkably simi-
lar to the fold depletion in SP cells. Interestingly, the myocar-
dial SP population also decreases with age, suggesting that
these cells may also be physiologically responsive to growth
demands in a non-disease myocardium (Fig. 2H).
The reduction in the MEF2Cdn SP cell population may
re£ect an activation/commitment process for this resident
stem cell pool. Indeed, activated stem cell populations display
evidence of lineage promiscuity. For example, stem cells de-
rived from other tissue sources have been demonstrated to
undergo lineage conversion when cultured with disparate
cell types [11^13]. As an initial step, we assayed myocardial
cell suspensions for the presence of stem cell progeny, i.e.
Fig. 1. FACS analysis of cardiac cell suspensions stained with
Hoechst dye (A), or Hoechst dye plus verapamil (B). Cardiac-de-
rived SP cells isolated from EGFP mice were co-cultured with wild-
type 1‡ cardiomyocytes. Di¡erentiated cardiomyocytes are marked
by connexin 43 (C), while cardiac-derived SP cells are GFP-positive
as indicated in panel D. The corresponding phase contrast image is
shown in panel E. Arrows identify cardiac-derived SP cells express-
ing the cardiomyocyte di¡erentiation marker, connexin 43. A wild-
type cardiomyocyte cell is shown (arrowhead). Panels G^I illustrate
the growth of an adhered stem cell-like colony contributing to the
expansion of a cardiomyocyte colony at 8 days (50U ; G) and 14
days (50U ; H). Day 14 is shown at 200U magni¢cation (I).
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colony formation using methylcellulose stem cell medium.
Myocardial cell suspensions derived from wild-type hearts
showed limited colony formation (Fig. 3A), yet MEF2Cdn
myocardial cell suspensions (cultured under the same condi-
tions) displayed robust hematopoietic colony formation (Fig.
3B^E). These colonies were comprised of both granulocytes
and monocytes as determined by GR-1 and MAC-1 staining,
respectively (Fig. 3F^H). The hematopoietic phenotypes of
the myocardial cell suspensions were similar to the cell types
derived from skeletal muscle-derived cell suspensions. How-
ever, the formation of hematopoietic colonies from myocar-
dial cell suspensions is considerably lower than that observed
for skeletal muscle (V10-fold di¡erence), although a robust
SP population is detectable from both sources [20]. In addi-
tion, FACS analyses using known stem cell markers for the
hematopoietic and skeletal muscle lineage indicate that the
cardiac SP population is not enriched for these proteins
(CD34, c-kit, Sca-1, Flk-2, Thy1.1; data not shown). As
Fig. 3. Comparison of the stem cell-like activity of cardiac-derived
SP cells between wild-type and MEF2Cdn mice, as determined by
the formation of hematopoietic colonies on methylcellulose medium.
Myocardial cell suspensions isolated from MEF2Cdn hearts show
on average 3.7 colonies per 10 000 cells plated compared to on aver-
age less than one colony per plate from wild-type heart cell suspen-
sions (A). Immunohistochemistry was performed on the colonies us-
ing hematopoietic markers GR-1 (F), and Mac-1 (G). Negative
controls are shown in panel H. Nuclei were stained with Hoechst
dye (I^G).
Fig. 2. Comparison of toluene blue-stained sections between wild-
type (A) and MEF2Cdn (B) ventricles. MEF2Cdn sections show an
increased density of nuclei compared to wild type. FACS analysis of
cardiac cells from ventricles of wild-type (C, D) and MEF2Cdn
(E, F) mice stained with Hoechst dye (C, E), or Hoechst dye plus
verapamil (D, F). Comparison of the size of the SP fraction in three
separate trials shows a s 2.5-fold increase in wild-type vs.
MEF2Cdn ventricles (G). Percentage of SP cells compared to total
cells in the post-natal heart decreases with progressive aging, as il-
lustrated in panel H.
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such, we interpret this surge in colony formation to be the
result of an in vivo stimulus to activate or commit a multi-
potent cell population, the stimulus in this instance being
limited myocardial growth.
To directly test the ability for lineage conversion in the
cardiac SP population, we puri¢ed myocardial SP cells from
the Z/AP marker mice and performed co-culture experiments
with non-cardiomyocyte cell types. The Z/AP strain utilizes a
strong promoter^enhancer combination to yield systemic ex-
pression of a lacZ transgene [15]. The puri¢ed myocardial SP
cells from Z/AP mice were capable of forming myotubes at a
high frequency when co-cultured with primary-derived skele-
tal muscle myoblasts and H9C2 rat cardiomyocytes (L-galac-
tosidase staining in the co-cultures V25% of cell total ; Fig.
4A,B). Although these results were suggestive of lineage con-
version/transdi¡erentiation, the apparent incorporation of the
SP cells into myotube structures may simply re£ect cell fusion
and not a true genetic reprogramming of the SP cell (a phe-
nomenon observed with other stem cell types; [25,26]). There-
fore, as an adjunct to the previous experiments we assayed the
ability of myocardial SP cells to convert to a skeletal muscle
genotype. The myocardial SP cells for these experiments were
derived from the Myf5/lacZ mouse. This strain has a lacZ
reporter gene targeted to the Myf5 locus, which ensures a
skeletal muscle-speci¢c expression pattern for the transgene
[27]. Myf5/lacZ myocardial SP cells were co-cultured with
both C2C12 skeletal muscle myoblasts and primary-derived
skeletal muscle myoblasts, then subject to a low serum-in-
duced di¡erentiation time course. C2C12 co-cultures had a
complete absence of L-gal staining (Fig. 4D,E) and primary
skeletal muscle co-cultures displayed a very low frequency of 1
in 100 000 cells (Fig. 4F,I). This apparent lack of transdi¡er-
entiation was con¢rmed using a second transgenic marker
strain with a ubiquitous expression pattern, the EGFP mouse
[16]. As indicated in Fig. 4J^L, GFP-positive cardiac-derived
SP cells were negative for the expression of the skeletal muscle
transcription factor myogenin when co-cultured with C2C12
myoblasts.
In summary, while it has been previously shown that nu-
merous tissue types possess stem cell populations, identi¢ca-
tion of an endogenous myocardial stem cell has not been
forthcoming. The results of the current study provide the ¢rst
evidence that the adult myocardium maintains a resident my-
ocardial stem cell-like population. Cardiac SP cells retain
characteristics of other stem cell populations, such as an ef-
fective fusion capacity with non-cardiac cell types. However,
cardiac SP cells do not readily convert their genotype/gene
expression pro¢le, which suggests a myocardial-restricted
function.
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